Live feed01:00:00·180dPRReleasevia QuantisnowORIC® Pharmaceuticals Presents Enozertinib Data in NSCLC Patients with HER2 Exon 20 Mutations at the ESMO Asia Congress 2025ByQuantisnow·Wall Street's wire, on your screen.ORIC· Oric Pharmaceuticals Inc.Health Care
